Enkhzaya Davaa

648 citations
20 papers · 507 indexed · h-index 10
Topics
Advanced Drug Delivery Systems (6 papers)RNA Interference and Gene Delivery (5 papers)Nanoparticle-Based Drug Delivery (5 papers)
Partner nations
South KoreaThailandChina

In The Last Decade

Enkhzaya Davaa

20 papers receiving 499 citations

Peers

Enkhzaya Davaa
Comparison fields: 5 of 87
  • Pharmaceutical Science 184
  • Molecular Biology 170
  • Biomaterials 148
  • Biomedical Engineering 98
  • Molecular Medicine 59
Replace Murtada A. Oshi with:
Murtada A. Oshi South Korea
Ping Gao China
Bharathi Karunakaran India
Liling Mei China
Unnati Garg India
Dhwani Rana India
Dengchao Xie China
Nimeet Desai India
Natallia V. Dubashynskaya Russia
Enkhzaya Davaa relative to Murtada A. Oshi South Korea Murtada A. Oshi's profile →
Citations per field
00.5×
Murtada A. Oshi · 1×
Citations per year

Countries citing papers authored by Enkhzaya Davaa

Since Specialization
Citations

This map shows the geographic impact of Enkhzaya Davaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enkhzaya Davaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enkhzaya Davaa more than expected).

Fields of papers citing papers by Enkhzaya Davaa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enkhzaya Davaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enkhzaya Davaa. The network helps show where Enkhzaya Davaa may publish in the future.

Co-authorship network of co-authors of Enkhzaya Davaa

This figure shows the co-authorship network connecting the top 25 collaborators of Enkhzaya Davaa. A scholar is included among the top collaborators of Enkhzaya Davaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enkhzaya Davaa. Enkhzaya Davaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 2
4 8
5 7
6 23
7 32
8 5
9 41
10 8
11 67
12 26
13 3
14 4
15 21
16 56
17 33
18 69
19 95
20 3

About Enkhzaya Davaa

Enkhzaya Davaa is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 20 papers that have together received 507 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (6 papers), RNA Interference and Gene Delivery (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). The work is most often cited by research in Pharmaceutical Science (184 citations), Molecular Medicine (59 citations) and Biomaterials (148 citations). Enkhzaya Davaa has collaborated with scholars based in South Korea, Thailand and China. Frequent co-authors include Jeong‐Sook Park, Chang‐Seon Myung, Hyunki Kim, Su‐Geun Yang, Se Jin Park, Sang‐Eun Lee, Rengarajan Baskaran, Seongbong Jo, Jin‐Ki Kim and Vivek Kumar Garripelli. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026